Long-term Outcomes of Cervical Adenocarcinoma Treated With Concurrent Chemoradiotherapy Using Paclitaxel and Cisplatin-Reference-Cited by-同舟云学术

Long-term Outcomes of Cervical Adenocarcinoma Treated With Concurrent Chemoradiotherapy Using Paclitaxel and Cisplatin

Published:2020 Issue:5 Volume:34 Page:2739-2743
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

ARAKAKI YOSHIHISA,ARIGA TAKURO,HEIANNA JOICHI,SHIMOJI YUKO,NAKASONE TADAHARU,TAIRA YUSUKE,NAKAMOTO TOMOKO,OOYAMA TAKUMA,KUDAKA WATARU,KANESHIMA ITOMI,NISHIHIRA KUMIKO,MEKARU KEIKO,AOKI YOICHI

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in Survival Outcomes Between Locally Advanced Cervical Squamous Cell Carcinoma and Adenocarcinoma Treated with Chemoradiotherapy;International Journal of Women's Health;2024-03

2. Study on the intake and efficacy of nab-paclitaxel in patients with advanced cervical cancer;European Journal of Gynaecological Oncology;2023

3. Based on the surveillance, epidemiology, and end results programme, to develop and validate nomograms for predicting overall survival and cancer-specific survival in geriatric patients with vulvar squamous cell carcinoma;European Journal of Gynaecological Oncology;2023

4. Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy;Anticancer Research;2022-10

5. Treatment Outcomes of Computer Tomography-Guided Brachytherapy in Cervical Cancer in Hong Kong: A Retrospective Review;Cancers;2022-08-15